We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Omnicom Group
OMC
$24.1B
| $382M | 0.57% |
4,904,568
-123,941
| -2% | -$9.46M |
|
52
EOG Resources
EOG
$75.8B
| $377M | 0.56% |
4,111,969
-304,138
| -7% | -$27.5M |
|
53
Zimmer Biomet
ZBH
$19B
| $375M | 0.56% |
3,282,511
+26,054
| +0.8% | +$2.97M |
|
54
International Paper
IP
$21.1B
| $371M | 0.55% |
7,055,556
-234,590
| -3% | -$12.2M |
|
55
Prudential Financial
PRU
$41.5B
| $369M | 0.55% |
4,596,457
+232,732
| +5% | +$18.9M |
|
|
56
Comcast
CMCSA
$93.7B
| $360M | 0.54% |
12,749,404
-11,215,792
| -47% | -$322M |
|
57
NXP Semiconductors
NXPI
$57B
| $350M | 0.52% |
3,492,390
+11,510
| +0.3% | +$1.01M |
|
58
Huntsman Corp
HUN
$1.69B
| $350M | 0.52% |
15,799,456
-370,884
| -2% | -$8.28M |
|
59
Verizon
VZ
$205B
| $349M | 0.52% |
7,178,566
-205,244
| -3% | -$9.91M |
|
60
Elevance Health
ELV
$86.6B
| $345M | 0.51% |
2,235,780
+1,739,509
| +351% | +$248M |
|
|
61
Trane Technologies
TT
$100B
| $336M | 0.5% |
+4,929,075
| New | +$326M |
|
|
GAP
62
The Gap Inc
GAP
$7.48B
| $330M | 0.49% |
7,625,488
-366,445
| -5% | -$15.3M |
|
|
XL
63
DELISTED
XL Group Ltd.
XL
| $326M | 0.49% |
8,856,540
+6,757,636
| +322% | +$242M |
|
64
Avery Dennison
AVY
$13.5B
| $304M | 0.45% |
5,752,042
-659,705
| -10% | -$34.9M |
|
65
Raymond James Financial
RJF
$33.9B
| $304M | 0.45% |
8,018,181
+1,115,113
| +16% | +$41.7M |
|
|
APC
66
DELISTED
Anadarko Petroleum
APC
| $303M | 0.45% |
+3,658,508
| New | +$299M |
|
67
Amgen
AMGN
$236B
| $298M | 0.44% |
1,862,303
+41,146
| +2% | +$6.48M |
|
68
Amdocs
DOX
$6.55B
| $297M | 0.44% |
5,454,632
+233,630
| +4% | +$11.8M |
|
|
QEP
69
DELISTED
QEP RESOURCES, INC.
QEP
| $291M | 0.43% |
13,937,577
-517,454
| -4% | -$10.8M |
|
70
Robert Half
RHI
$4.6B
| $290M | 0.43% |
4,787,797
+368,623
| +8% | +$22.2M |
|
71
Parker-Hannifin
PH
$127B
| $282M | 0.42% |
2,371,967
+112,810
| +5% | +$13.7M |
|
72
Cardinal Health
CAH
$54.7B
| $281M | 0.42% |
3,110,481
+111,804
| +4% | +$9.63M |
|
73
MetLife
MET
$61.2B
| $276M | 0.41% |
6,129,466
-232,638
| -4% | -$10.5M |
|
|
AMTD
74
DELISTED
TD Ameritrade Holding Corp
AMTD
| $274M | 0.41% |
7,363,845
+178,511
| +2% | +$6.35M |
|
75
Arrow Electronics
ARW
$10.6B
| $273M | 0.41% |
4,464,762
-334,593
| -7% | -$19.9M |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.